Translating science into human health
Science
A New Way to Prevent Scarring
Scarring is more than a cosmetic concern; it can alter tissue structure and function, compromise normal tissue properties, and negatively affect self-confidence, mental well-being, and overall quality of life.
Despite its widespread impact, most existing scar-care approaches, including silicone gels, steroid injections, pressure garments, and laser treatments, primarily focus on managing scars after they become visible, rather than addressing the biological processes that drive excessive scar formation during wound healing.
A key unmet need lies in addressing immune cell dysregulation during the early stages of wound healing, when the body's inflammatory and immune responses play a critical role in determining tissue repair outcomes. CYTONECT™ is developing a proprietary nanomedicine technology designed to intervene at this early stage by modulating immune cell activity and promoting a more balanced healing response. By addressing the underlying biological mechanisms associated with excessive scarring, the technology aims to reduce excessive scar tissue formation while supporting healthier tissue repair and regeneration.
The Market Opportunity
Growing Demand for Advanced Wound Care & Scar Management Solutions
The growing demand for advanced wound care and scar-management solutions presents a significant opportunity for innovation. With the global wound care and scar treatment markets projected to expand substantially, there is increasing potential for next-generation technologies that address the biological processes underlying excessive scar formation. CYTONECT™ aims to address this opportunity through its proprietary immune-modulating nanomedicine technology.
Total Wound Care Market
2025:
$25.07B
Projected by 2033:
$35.13B
Advanced Wound Care
2025:
$11.7B
Projected by 2033:
$17.8B
Primary Target
Scar Treatment
10.6% CAGR
2025:
$2.85B
Projected by 2033:
$6.45B
Source: Grand View Research (2025 estimates; 2033 projections)